The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers

por Hye Ryeon Kim, Hye Ryeon Kim, Soomin Ahn, Hyunji Jo, Hongsik Kim, Joohyun Hong, Jeeyun Lee, Ho-Yeong Lim, Won Ki Kang, Seung Tae Kim
Publicado 2021

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach

por Hana Kim, Hyo Jung Kim, Hongsik Kim, Hye Ryeon Kim, Hyunji Jo, Joohyun Hong, Ryul Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Se Kyung Lee, Haeyoung Kim, Soo-Yong Shin, Yeon Hee Park
Publicado 2021

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

por Hongsik Kim MD, Hana Kim MD, Ryul Kim MD, PhD, Hyunji Jo MD, Hye Ryeon Kim MD, Joohyun Hong MD, PhD, Joon Oh Park MD, PhD, Young Suk Park MD, PhD, Seung Tae Kim MD, PhD
Publicado 2021